Neil Finnen, MD
Ophthalmology · Carmel, INNPI 1225014848
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (58.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Apellis Pharmaceuticals, Inc. at 25.5% of the total. Among ophthalmology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 82 payments — averaging $116.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Apellis Pharmaceuticals, Inc.$2K
- Eyepoint US, Inc.$2K
- Novartis$2K
- AbbVie$571
- Ocular Therapeutix, Inc.$491
- Alimera Sciences, Inc.$405
- plus $1K from 8 others
Across 73 payments — averaging $76,528 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$5.4M
- Janssen Research & Development, LLC$113K
- Ocular Therapeutix, Inc.$28K
- Eyepoint US, Inc.$5K
What the payments were for
- Consulting fees$501%
- Travel & lodging$5,56058%
- Food & beverage$3,93641%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 11 | $2,432 |
| Eyepoint US, Inc. | 6 | $2,355 |
| Novartis | 11 | $1,847 |
| AbbVie(2 entities) | 6 | $571 |
| Ocular Therapeutix, Inc. | 8 | $491 |
| Alimera Sciences, Inc. | 10 | $405 |
| Astellas Pharma US Inc | 6 | $319 |
| Genentech USA, Inc. | 3 | $284 |
| US Oncology Corporate, Inc. | 1 | $202 |
| ANI Pharmaceuticals, Inc. | 10 | $198 |
| Janssen Global Services, LLC | 1 | $177 |
| Regeneron Healthcare Solutions, Inc. | 7 | $124 |
| Amgen | 1 | $91 |
| Regeneron | 1 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,545 in reported general payments places this provider in the 90th percentile of 266 ophthalmology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 247 | $11,647 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 44 | $6,672 |
| ProlensaBromfenac Sodium | 11 | $3,748 |
| RocklatanNetarsudil Mesylat/Latanoprost | 11 | $3,744 |
| Bromfenac Sodium | 13 | $2,562 |
| Acetazolamide | 34 | $2,473 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 11 | $2,310 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 104 | $1,394 |
| Atropine Sulfate | 34 | $1,215 |
| Ondansetron Hcl | 140 | $849 |
| Latanoprost | 134 | $806 |
| ValacyclovirValacyclovir Hcl | 20 | $340 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 88 | $291 |
| ErythromycinErythromycin Base | 20 | $177 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 16 | $170 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Carmel
- Michael BehforouzCarmel$17K
- Michael HopenCarmel$11K
- Thomas CiullaCarmel$7K
- Shamik BafnaLafayette$505K
- Kevin WaltzIndianapolis$199K
- Janet HummerIndianapolis$96K
- Francis PriceIndianapolis$67K
- Omar DukarEvansville$43K
- Gerald RoperBatesville$34K
- Dwight SilveraEvansville$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.